Selenium, Aspirin May Have Benefit in Prostate Cancer
An observational study suggests that selenium and aspirin may modify a high genetic risk for prostate cancer.
An observational study suggests that selenium and aspirin may modify a high genetic risk for prostate cancer.
Researchers identify a relationship between exercise activity and television habits in relation to mortality in survivors of colorectal cancer.
Biochemotherapy prolongs relapse-free survival in malignant melanoma compared with high-dose interferon, but newer agents are safer and more effective.
Case-control studies found no evidence of neurological or cardiac impairment in children exposed to chemotherapy or radiotherapy in utero.
Using the right combination of drugs at a critical point in tumor evolution may stop the progression of heterogeneous tumors.
The right time for American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) on metastatic castration-resistant prostate cancer.
The new test is more sensitive than fecal occult blood tests but carries a higher risk of false-positives.
A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.
Changes in adipose tissue precede the development of cachexia symptoms, and suggest a treatment approach.
A topical gel containing an active metabolite of tamoxifen suppressed cell proliferation equally as well as the oral form.